HTL0039732

About Nxera Pharma

Nxera Pharma is a Tokyo-based, publicly traded biopharmaceutical company with a mission to deliver transformative medicines by exploiting its proprietary expertise in G protein-coupled receptor (GPCR) structure-based drug design. The company has successfully evolved from a technology licensing model into a robust, pipeline-driven enterprise with 16+ assets, underpinned by its StaR® technology platform and a dual-hub operational model spanning Japan and the UK. Its strategy focuses on advancing internal neuroscience and immuno-oncology candidates while generating significant value through strategic partnerships with major global pharmaceutical companies, positioning it as a key player in the next generation of GPCR-targeted therapeutics.

Therapeutic Areas

Other Oncology (Immuno-oncology) Drugs